PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0033860|psoriasis |
| Sentences | 25 |
| PubMedID- 24474126 | Corroborating these findings, patients with severe psoriasis have marked incidence of psoriatic arthritis, cardiovascular diseases, hypertension, dyslipidemia, obesity and diabetes mellitus, showing an increased risk for acute myocardial infarction, which suggests that the condition is not restricted to the skin. |
| PubMedID- 26300652 | There is overwhelming evidence on the higher risk of cardiovascular diseases in patients with psoriasis as a result of hyperlipidemia, which is more common in these patients. |
| PubMedID- 23006590 | These findings emphasize the increased burden of cardiovascular disease in patients with psoriasis and they call for further studies in this area of research. |
| PubMedID- 22963528 | Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a danish real-world cohort study. |
| PubMedID- 25622660 | With increasing awareness that psoriasis is associated with cardiovascular disease and metabolic syndrome, patients may also seek to improve diet to prevent these comorbidities. |
| PubMedID- 24238156 | psoriasis was associated with cardiovascular disease in total (odds ratio [or] 1.4; 95% confidence interval [ci] 1.2-1.7), ischemic heart disease (or 1.5; 95% ci 1.2-1.9), peripheral vascular disease (or 1.5; 95% ci 1.2-1.8), atherosclerosis (or 1.1; 95% ci 1.1-1.2), diabetes (or 1.9; 95% ci 1.5-2.5), hypertension (or 1.8; 95% ci 1.6-2.0), dyslipidemia (or 1.5; 95% ci 1.4-1.7), obesity by body mass index (or 1.8; 95% ci 1.4-2.2), obesity by abdominal fat (or 1.6; 95% ci 1.2-2.3), and the metabolic syndrome (or 1.8; 95% ci 1.2-2.8), but not associated with cerebrovascular disease (or 1.1; 95% ci 0.9-1.3) and cardiovascular mortality (or 0.9; 95% ci 0.4-2.2). |
| PubMedID- 24860744 | [14] increased mortality from cardiovascular disease in patients with severe psoriasis has been documented and psoriasis may be an independent risk factor for myocardial infarction, especially in young patients. |
| PubMedID- 26121943 | What is more, a number of studies and observations confirm an increased occurrence of the standard atherosclerosis risk factors and/or metabolic syndrome as well as cardiovascular diseases in patients with psoriasis [9, 18, 22, 27, 35, 45]. |
| PubMedID- 24138455 | Co-morbidities include psoriatic arthritis [9], crohn’s disease [10] and in severe psoriasis, an increased risk of cardiovascular disease (cvd) and of diabetes [11,12]. |
| PubMedID- 24504802 | Hypercholesterolemia is a major risk factor for cardiovascular disease, and patients with psoriasis or psoriatic arthritis (psa) have been shown to have elevated cholesterol levels. |
| PubMedID- 24161194 | An interdisciplinary approach is needed to find the necessary steps beyond classic risk reduction and detection of early cardiovascular disease in patients with psoriasis, as well as to develop a cardiovascular disease preventive regimen. |
| PubMedID- 23058814 | Background: psoriasis has been associated with cardiovascular diseases, but its relationship to markers of subclinical atherosclerosis has not been fully elucidated. |
| PubMedID- 25752901 | Objectives: an increased risk for cardiovascular disease with psoriasis has been reported. |
| PubMedID- 24082881 | A number of studies suggest a high prevalence of cardiovascular risk factors as well as cardiovascular diseases in psoriasis patients. |
| PubMedID- 25291969 | Increased serum c-reactive protein level in japanese patients of psoriasis with cardio- and cerebrovascular disease. |
| PubMedID- 26422385 | psoriasis is associated with increased cardiovascular disease (cvd) in adults, but the risk profile of children with psoriasis remains to be fully characterized. |
| PubMedID- 25896794 | Therefore, while tnf-alpha inhibitors were shown to reduce development of cardiovascular disease in patients with psoriasis [27], no evidence regarding such an effect is available in pemphigus. |
| PubMedID- 22175820 | psoriasis and risk of nonfatal cardiovascular disease in u.s. |
| PubMedID- 24748809 | Patients with moderate-then-low adherence were also more likely to have the psoriasis-related comorbidity of peripheral vascular disease/cerebrovascular disease/coronary heart disease. |
| PubMedID- 24599540 | A combinational therapy for patients with severe psoriasis associated with cardiovascular disease. |
| PubMedID- 23636854 | Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris. |
| PubMedID- 23491525 | Indeed, systemic inflammation may contribute to both dm and cardiovascular disease in patients with psoriasis (31). |
| PubMedID- 24320841 | psoriasis is associated with cardiovascular diseases (cvd). |
| PubMedID- 22161801 | Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis. |
| PubMedID- 24584215 | The risk of cardiovascular diseases in psoriasis has been shown in several studies [2–4]. |
Page: 1